HEADER GENE REGULATION 19-JUL-00 1FD0 TITLE ISOTYPE SELECTIVITY OF THE HUMAN RETINOIC ACID NUCLEAR RECEPTOR HRAR: TITLE 2 THE COMPLEX WITH THE RARGAMMA-SELECTIVE RETINOID SR11254 COMPND MOL_ID: 1; COMPND 2 MOLECULE: RETINOIC ACID RECEPTOR GAMMA-1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN; COMPND 5 SYNONYM: RAR-GAMMA-1; COMPND 6 ENGINEERED: YES; COMPND 7 OTHER_DETAILS: COMPLEXED WITH SR11254, RESIDUE 254 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PET-15B KEYWDS ISOTYPE SELECTIVITY, RETINOID LIGAND COMPLEXES, DRUG DESIGN, KEYWDS 2 ANTIPARALLEL ALPHA-HELICAL SANDWICH FOLD, CH...O HYDROGEN BOND, KEYWDS 3 STRUCTURAL PROTEOMICS IN EUROPE, SPINE, STRUCTURAL GENOMICS, GENE KEYWDS 4 REGULATION EXPDTA X-RAY DIFFRACTION AUTHOR B.P.KLAHOLZ,D.MORAS,STRUCTURAL PROTEOMICS IN EUROPE (SPINE) REVDAT 5 09-AUG-23 1FD0 1 REMARK REVDAT 4 24-JUL-19 1FD0 1 REMARK REVDAT 3 24-FEB-09 1FD0 1 VERSN REVDAT 2 01-APR-03 1FD0 1 JRNL REVDAT 1 27-SEP-02 1FD0 0 JRNL AUTH B.KLAHOLZ,D.MORAS JRNL TITL C-H...O HYDROGEN BONDS IN THE NUCLEAR RECEPTOR RARGAMMA--A JRNL TITL 2 POTENTIAL TOOL FOR DRUG SELECTIVITY. JRNL REF STRUCTURE V. 10 1197 2002 JRNL REFN ISSN 0969-2126 JRNL PMID 12220491 JRNL DOI 10.1016/S0969-2126(02)00828-6 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH B.P.KLAHOLZ,A.MITSCHLER,M.BELEMA,C.ZUSI,D.MORAS REMARK 1 TITL ENANTIOMER DISCRIMINATION ILLUSTRATED BY HIGH-RESOLUTION REMARK 1 TITL 2 CRYSTAL STRUCTURES OF THE HUMAN NUCLEAR RECEPTOR HRARGAMMA. REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 97 6322 2000 REMARK 1 REFN ISSN 0027-8424 REMARK 1 DOI 10.1073/PNAS.97.12.6322 REMARK 1 REFERENCE 2 REMARK 1 AUTH B.P.KLAHOLZ,J.-P.RENAUD,A.MITSCHLER,C.ZUSI,P.CHAMBON, REMARK 1 AUTH 2 H.GRONEMEYER,D.MORAS REMARK 1 TITL CONFORMATIONAL ADAPTATION OF AGONISTS TO THE HUMAN NUCLEAR REMARK 1 TITL 2 RECEPTOR HRARGAMMA. REMARK 1 REF NAT.STRUCT.BIOL. V. 5 199 1998 REMARK 1 REFN ISSN 1072-8368 REMARK 1 REFERENCE 3 REMARK 1 AUTH J.-P.RENAUD,N.ROCHEL,V.VIVAT,P.CHAMBON,H.GRONEMEYER,D.MORAS REMARK 1 TITL CRYSTAL STRUCTURE OF THE RARGAMMA LIGAND-BINDING DOMAIN REMARK 1 TITL 2 BOUND TO ALL-TRANS RETINOIC ACID. REMARK 1 REF NATURE V. 378 681 1995 REMARK 1 REFN ISSN 0028-0836 REMARK 1 DOI 10.1038/378681A0 REMARK 2 REMARK 2 RESOLUTION. 1.38 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.38 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 6.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.131 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.131 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.158 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 2910 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 58146 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.124 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.123 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.150 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 2556 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 50280 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1851 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 65 REMARK 3 SOLVENT ATOMS : 331 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 2200.2 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 1935.0 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 24 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 21188 REMARK 3 NUMBER OF RESTRAINTS : 26389 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.013 REMARK 3 ANGLE DISTANCES (A) : 0.031 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.025 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.073 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.077 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.023 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.004 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.038 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.093 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: MOEWS & KRETSINGER, J.MOL.BIOL.91(1973)201-228 REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH & HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: ANISOTROPIC REFINEMENT REDUCED FREE R REMARK 3 (NO CUTOFF) BY 2.4% REMARK 4 REMARK 4 1FD0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 04-AUG-00. REMARK 100 THE DEPOSITION ID IS D_1000011490. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-JUL-98 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : EMBL/DESY, HAMBURG REMARK 200 BEAMLINE : BW7B REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8345 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 59004 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.380 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 4.930 REMARK 200 R MERGE (I) : 0.04200 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 36.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.38 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.41 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 4.00 REMARK 200 R MERGE FOR SHELL (I) : 0.36200 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: 1FCY REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.10 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SODIUM ACETATE, PH 7.0, VAPOR REMARK 280 DIFFUSION, HANGING DROP AT 290K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+1/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+3/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+1/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+3/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 77.84400 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 29.89450 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 29.89450 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 38.92200 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 29.89450 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 29.89450 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 116.76600 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 29.89450 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 29.89450 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 38.92200 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 29.89450 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 29.89450 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 116.76600 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 77.84400 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 SER A 183 N - CA - CB ANGL. DEV. = 13.0 DEGREES REMARK 500 HIS A 218 CA - CB - CG ANGL. DEV. = 11.5 DEGREES REMARK 500 ASP A 228 CB - CG - OD1 ANGL. DEV. = 6.2 DEGREES REMARK 500 ARG A 247 NE - CZ - NH2 ANGL. DEV. = -7.0 DEGREES REMARK 500 ARG A 296 NE - CZ - NH1 ANGL. DEV. = 4.1 DEGREES REMARK 500 ASP A 325 CB - CG - OD2 ANGL. DEV. = -5.7 DEGREES REMARK 500 ARG A 341 NE - CZ - NH1 ANGL. DEV. = 3.5 DEGREES REMARK 500 ASP A 351 CB - CG - OD2 ANGL. DEV. = -6.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 215 54.23 36.39 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 254 A 450 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE LMU A 451 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2LBD RELATED DB: PDB REMARK 900 CONTAINS THE SAME PROTEIN COMPLEXED WITH ALL-TRANS RETINOIC ACID REMARK 900 RELATED ID: 3LBD RELATED DB: PDB REMARK 900 CONTAINS THE SAME PROTEIN COMPLEXED WITH 9-CIS RETINOIC ACID REMARK 900 RELATED ID: 1EXA RELATED DB: PDB REMARK 900 CONTAINS THE SAME PROTEIN COMPLEXED WITH THE RETINOID BMS270394 REMARK 900 RELATED ID: 1EXX RELATED DB: PDB REMARK 900 CONTAINS THE SAME PROTEIN COMPLEXED WITH THE RETINOID BMS270395 REMARK 900 RELATED ID: 1FCZ RELATED DB: PDB REMARK 900 CONTAINS THE SAME PROTEIN COMPLEXED WITH THE RETINOID BMS181156 REMARK 900 RELATED ID: 1FCY RELATED DB: PDB REMARK 900 CONTAINS THE SAME PROTEIN COMPLEXED WITH THE RETINOID CD564 REMARK 900 RELATED ID: 1FCX RELATED DB: PDB REMARK 900 CONTAINS THE SAME PROTEIN COMPLEXED WITH THE RETINOID BMS184394 REMARK 900 RELATED ID: IGBMC-0078-000 RELATED DB: TARGETDB DBREF 1FD0 A 183 417 UNP P13631 RARG1_HUMAN 183 417 SEQRES 1 A 235 SER PRO GLN LEU GLU GLU LEU ILE THR LYS VAL SER LYS SEQRES 2 A 235 ALA HIS GLN GLU THR PHE PRO SER LEU CYS GLN LEU GLY SEQRES 3 A 235 LYS TYR THR THR ASN SER SER ALA ASP HIS ARG VAL GLN SEQRES 4 A 235 LEU ASP LEU GLY LEU TRP ASP LYS PHE SER GLU LEU ALA SEQRES 5 A 235 THR LYS CYS ILE ILE LYS ILE VAL GLU PHE ALA LYS ARG SEQRES 6 A 235 LEU PRO GLY PHE THR GLY LEU SER ILE ALA ASP GLN ILE SEQRES 7 A 235 THR LEU LEU LYS ALA ALA CYS LEU ASP ILE LEU MET LEU SEQRES 8 A 235 ARG ILE CYS THR ARG TYR THR PRO GLU GLN ASP THR MET SEQRES 9 A 235 THR PHE SER ASP GLY LEU THR LEU ASN ARG THR GLN MET SEQRES 10 A 235 HIS ASN ALA GLY PHE GLY PRO LEU THR ASP LEU VAL PHE SEQRES 11 A 235 ALA PHE ALA GLY GLN LEU LEU PRO LEU GLU MET ASP ASP SEQRES 12 A 235 THR GLU THR GLY LEU LEU SER ALA ILE CYS LEU ILE CYS SEQRES 13 A 235 GLY ASP ARG MET ASP LEU GLU GLU PRO GLU LYS VAL ASP SEQRES 14 A 235 LYS LEU GLN GLU PRO LEU LEU GLU ALA LEU ARG LEU TYR SEQRES 15 A 235 ALA ARG ARG ARG ARG PRO SER GLN PRO TYR MET PHE PRO SEQRES 16 A 235 ARG MET LEU MET LYS ILE THR ASP LEU ARG GLY ILE SER SEQRES 17 A 235 THR LYS GLY ALA GLU ARG ALA ILE THR LEU LYS MET GLU SEQRES 18 A 235 ILE PRO GLY PRO MET PRO PRO LEU ILE ARG GLU MET LEU SEQRES 19 A 235 GLU HET 254 A 450 41 HET LMU A 451 35 HETNAM 254 6-[HYDROXYIMINO-(5,5,8,8-TETRAMETHYL-5,6,7,8- HETNAM 2 254 TETRAHYDRO-NAPHTALEN-2-YL)-METHYL]-NAPHTALENE-2- HETNAM 3 254 CARBOXYLIC ACID HETNAM LMU DODECYL-ALPHA-D-MALTOSIDE HETSYN 254 SR11254 FORMUL 2 254 C26 H27 N O3 FORMUL 3 LMU C24 H46 O11 FORMUL 4 HOH *331(H2 O) HELIX 1 1 SER A 183 PHE A 201 1 19 HELIX 2 2 ASP A 223 ARG A 247 1 25 HELIX 3 3 GLY A 250 LEU A 254 5 5 HELIX 4 4 SER A 255 THR A 277 1 23 HELIX 5 5 ARG A 296 GLY A 303 1 8 HELIX 6 6 PHE A 304 PRO A 306 5 3 HELIX 7 7 LEU A 307 LEU A 319 1 13 HELIX 8 8 PRO A 320 GLU A 322 5 3 HELIX 9 9 ASP A 324 ILE A 337 1 14 HELIX 10 10 GLU A 346 ARG A 369 1 24 HELIX 11 11 TYR A 374 MET A 402 1 29 HELIX 12 12 PRO A 409 GLU A 417 1 9 SHEET 1 A 3 TYR A 279 THR A 280 0 SHEET 2 A 3 THR A 285 THR A 287 -1 O THR A 285 N THR A 280 SHEET 3 A 3 THR A 293 ASN A 295 -1 N LEU A 294 O MET A 286 SITE 1 AC1 15 PHE A 201 PHE A 230 ALA A 234 CYS A 237 SITE 2 AC1 15 LEU A 271 MET A 272 ILE A 275 ARG A 278 SITE 3 AC1 15 PHE A 288 SER A 289 GLY A 303 PHE A 304 SITE 4 AC1 15 LEU A 400 ILE A 412 HOH A 549 SITE 1 AC2 18 LYS A 240 GLU A 243 LEU A 263 CYS A 267 SITE 2 AC2 18 ASP A 340 GLN A 354 PRO A 377 LEU A 380 SITE 3 AC2 18 ILE A 383 THR A 384 ARG A 387 MET A 415 SITE 4 AC2 18 HOH A 561 HOH A 607 HOH A 648 HOH A 688 SITE 5 AC2 18 HOH A 747 HOH A 782 CRYST1 59.789 59.789 155.688 90.00 90.00 90.00 P 41 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016725 0.000000 0.000000 0.00000 SCALE2 0.000000 0.016725 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006423 0.00000